Tetrahydroisoquinoline derivatives as highly selective and potent Rho kinase inhibitors.
Fang X, Yin Y, Chen YT, Yao L, Wang B, Cameron MD, Lin L, Khan S, Ruiz C, Schröter T, Grant W, Weiser A, Pocas J, Pachori A, Schürer S, Lograsso P, Feng Y.
Fang X, et al. Among authors: yin y.
J Med Chem. 2010 Aug 12;53(15):5727-37. doi: 10.1021/jm100579r.
J Med Chem. 2010.
PMID: 20684608